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Abstract Recent developments have led to advances in our
understanding of the structure and mechanism of action of
proton-translocating (or AB) transhydrogenase. There is (a) a
high-resolution crystal structure, and an NMR structure, of the
NADP(H)-binding component (dIII), (b) a homology-based
model of the NAD(H)-binding component (dI) and (c) an
emerging consensus on the position of the transmembrane helices
(in dII). The crystal structure of dIII, in particular, provides new
insights into the mechanism by which the energy released in
proton translocation across the membrane is coupled to changes
in the binding affinities of NADP and NADPH that drive the
chemical reaction.
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1. Introduction
Transhydrogenase couples the transfer of reducing equiva-
lents between NAD(H) and NADP(H) to the translocation of
protons across a membrane.
NADHNADP  xHpINAD NADPH xHn 1
where Hp and H

n signify the involvement of protons in the p
and n aqueous phases, respectively. The enzyme is found in
the inner membranes of higher-animal mitochondria, and in
the cytoplasmic membranes of many, though not all, bacteria.
In some protozoan parasites lacking functional mitochondria,
transhydrogenase is located in other membranes of the cell [1].
It is absent from Saccharomyces cerevisiae [2]. There was a
suggestion from biochemical experiments that transhydroge-
nase is present in plant mitochondria [3], although it has not
been identi¢ed in the available genome sequence of Arabidop-
sis thaliana [4]. It is present in the green alga Acetabularia
acetabulum [5].
NAD(H) and NADP(H) are the major, soluble redox co-
factors of living cells. Although there are exceptions to the
rule, NAD(H) is generally involved in catabolism, and
NADP(H) in anabolism. Thus, the redox potentials of
NAD(H) and NADP(H) in the same aqueous compartment
of the cell can be separately regulated to permit independent
control of the energy-yielding and energy-consuming arms of
metabolism. Transhydrogenase sits at the interface between
these two important cofactor pools. Under most physiological
conditions the enzyme probably operates from left to right
(Eq. 1), consuming the proton electrochemical gradient (vp)
generated by respiratory (or, in some bacteria, photosynthetic)
electron transport. Its function is organism- and tissue-de-
pendent [6]. It can contribute to NADPH formation for bio-
synthesis and glutathione reduction [7], in the regulation of
£ux through the tricarboxylic acid cycle [8], and, operating in
reverse in some invertebrates, it can transfer reducing power
from NADPH to NAD to fuel an anaerobic respiratory
chain [9].
Extensive earlier reviews on transhydrogenase have been
published [10^14]. The non-proton-pumping, or BB transhy-
drogenase [15] will not be discussed here.
2. An overview of the structure and elementary properties of
transhydrogenase
Transhydrogenase has a tripartite arrangement of subunits
(Fig. 1). Even though there is some domain rearrangement at
the genetic level (see [16]), there appears to be little variation
in the structural organisation of the enzyme from di¡erent
species. The dI component (V400 amino acid residues),
which binds NAD and NADH, and the dIII component
(V200 residues), which binds NADP and NADPH, pro-
trude from the membrane, on the matrix side in animal mi-
tochondria and on the cytoplasmic side in bacteria [16^20].
The dII component (V400 residues) spans the membrane.
The native enzyme is thought to be dimeric [21,22], though
this might not be of functional signi¢cance.
As with all the ‘soluble’ dehydrogenases [23], it is not
known whether the redox step in transhydrogenase involves
the transfer of H3, (2e3+H) or (e3+HW) between the nucleo-
tides. In this review, the term ‘hydride’ is taken formally to
represent ‘hydride-ion equivalent’. Though it remained unde-
tected for many years, there is a deuterium isotope e¡ect (kH/
kD = 1.8^4.5) in the transhydrogenation reaction, in both
steady-state [24,25] and transient-state [26] conditions. The
isotope e¡ect has an interesting temperature dependence
[26]. Hydride transfer is between the 4A (or pro-R) position
on the nicotinamide ring of NAD(H) and the 4B (or pro-S)
position on that of NADP(H) [27].
Recombinant forms of isolated dI and dIII have now been
isolated from a number of species [28^33]. Simple mixtures of
dI and dIII proteins, even from di¡erent species, catalyse a
rapid, single turnover of hydride transfer between bound nu-
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cleotides [26,33^35]. This shows that the apparatus for hy-
dride transfer is located entirely within dI and dIII, i.e. the
membrane-spanning dII component is not involved in the re-
dox step. Analysis of steady-state kinetics of complete trans-
hydrogenase established that the reaction proceeds through a
ternary complex (e.g. enzyme.NADH.NADP), as originally
shown [36]. There is now little doubt that transfer of hydride
proceeds directly between the two C4 atoms on the nicotin-
amide rings of the bound nucleotides: (a) isolated dI and dIII
are not associated with detectable redox cofactors or pros-
thetic groups [34], (b) in stopped-£ow experiments with mix-
tures of dI and dIII, the single turnover reduction of
AcPdAD, bound to dI, has similar kinetics to the oxidation
of NADPH, bound to dIII [34]; equivalently, the single turn-
over oxidation of AcPdADH, on dI, matches the reduction of
NADP, on dIII [35]. Thus, there are no reduced enzyme
intermediates in the reaction catalysed by transhydrogenase.
In early experiments to determine the value of x in Eq. 1,
rates of transhydrogenation, and of proton leak, were both
underestimated (sometimes producing fortuitously accurate
ratios, as discussed in [37]). Recent measurements, performed
on a much faster time scale to minimise errors, indicate that,
for both the bacterial and mitochondrial proteins, one proton
is translocated across the membrane per hydride transferred
[38]. Complexes of dI and dIII catalyse a rapid single turnover
of hydride transfer (see above) but, in the absence of dII, the
steady-state reaction is very heavily limited by the extremely
slow rate of release of either NADPH (during forward trans-
hydrogenation), or of NADP (during reverse) [30]. It would
appear that, in the intact enzyme, interactions between dII
Fig. 1. The structure of transhydrogenase, facts and fantasies. The ribbon diagram of dIII (left) is a representation of the crystal structure of
human dIII.NADP [69]. That of dI (right) is a homology-based model [59] using the crystal structure of alanine dehydrogenase [62] as a tem-
plate. Fourteen TM helices in dII (below) are indicated, the consensus number for mitochondrial transhydrogenase (see text). The ¢gure (in an
‘exploded’ view) indicates possible interactions between dI, dII and dIII. The ridge on dIII is proposed to insert into the putative cleft of dI to
bring the nicotinamide rings of NADP and NADH into apposition, and helix-D/loop-D of dIII is proposed to interact with the interstitial
loops between TM helices on dII.
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and dIII, probably coupled to proton translocation (see be-
low), promote release of NADP(H).
3. A binding-change mechanism for proton translocation by
transhydrogenase
The facts that hydride transfer between nucleotides is direct
(see above), and that there is no isotopic exchange of the
hydride transferred and the solvent water [27], together
strongly suggest that the redox reaction is not itself coupled
to proton translocation. In fact, the notion that conforma-
tional rearrangements in the protein are responsible for pro-
ton pumping was put forward by Rydstro«m more than 20
years ago [39]. Following Boyer’s proposals for energy cou-
pling in ATP synthase (see [40]), it was suggested, if only in
broad terms, that proton translocation by transhydrogenase
might also be associated with changes in the binding of
NAD(H) and NADP(H) [41,42]. The observation that sus-
ceptibility of transhydrogenase to inhibitory modi¢cation by
various agents was di¡erentially a¡ected by NADP and
NADPH led to the suggestion that conformational changes
at the NADP(H)-binding site are of particular importance
[43]. However, the view persisted that changes in binding of
both NAD(H) and NADP(H) are coupled to proton trans-
location [44]. In 1994, on the basis of observations on the
‘cyclic reaction’ in Escherichia coli transhydrogenase [45], we
proposed that proton translocation is coupled speci¢cally to
changes in the binding of NADP and NADPH, and the
gating requirements of such a mechanism were de¢ned.
Present evidence strongly supports the notion that NADH
serves only as a passive donor of reducing equivalents in the
reaction [46^48]. A working hypothesis is shown in Fig. 2.
Binding of NADP to dIII leads to a state of the enzyme
(E*.NADP) in which protonation from the p side of the
membrane is permitted. Protonation drives the enzyme into
a state (E**) capable of hydride transfer ^ the two C4 atoms
on the nicotinamide rings of NADP and NADH are brought
into apposition. Following hydride transfer, deprotonation of
the enzyme to the n side then regenerates E* which allows
rapid release of NADPH.
4. Transmembrane helices in the dII component of
transhydrogenase
A range of predictive algorithms and experimental ap-
proaches has been employed to determine the number and
position of transmembrane (TM) helices in dII [16^18,49^
52]. The emerging consensus (extensively reviewed [52]) is
that there are 13 TM helices in transhydrogenases from pro-
karyotes (including E. coli, Rhodospirillum rubrum, and
others), and certain protozoan parasites [53], and 14 in the
enzyme from mitochondria of higher animals; the extra helix
in the last group is located in a short sequence which is miss-
ing in bacteria. A comparison of the organisation of genes
coding for transhydrogenase indicates that there are two clus-
ters of TM helices (numbers 1^4 and 6^14 in the adopted
nomenclature [18,52]), which in many species are separately
transcribed. Whether this is of structural or functional signi¢-
cance remains to be seen. All the conserved, protonatable
residues in the putative TM helices of E. coli transhydroge-
nase, and their interstitial loops, have been replaced by site-
directed mutagenesis [50,54^58], but most substitutions have,
at most, only a partial e¡ect on activity. Replacement of LH91
by other residues gave rise to decreased transhydrogenation
rates, and it was suggested that this residue is involved in
proton pumping [50,55,58]. However, there are ¢ve recently
determined genome sequences from which it appears that the
equivalent histidine residue is replaced by an asparagine. It is
unlikely, therefore, that the residue in this position plays other
than a passive role in proton translocation in transhydroge-
nase. The probability is that the proton channel through dII
comprises mainly bound water molecules and the side chains
of serine and threonine residues.
5. A model of the 3-D structure of the dI component of
transhydrogenase based on the high-resolution structure of
alanine dehydrogenase
The existence of a ¢ngerprint region [59] in the amino acid
sequences provided evidence that a part of dI has the com-
mon, dinucleotide-binding fold [16^18,49,60]. It was noted
Fig. 2. A binding-change mechanism for transhydrogenase. E, E*
and E** are di¡erent conformations of the complete, membrane-
bound transhydrogenase. The catalytic site is linked to the solvent
by two proton channels, on the outside of the membrane, by the p
channel, and on the inside, by the n channel. The reaction is gated
to prevent hydride transfer without proton translocation, and vice
versa. a: Hydride transfer can take place in E** but not in E or
E*. b: The p channel is open, and the n channel is closed, when
NADP is bound to the enzyme, whereas the p channel is closed,
and the n channel is open, when NADPH is bound. c: In both the
E and E* states, NADP(H) on the enzyme can exchange rapidly
with nucleotide in the solvent (binding is signi¢ed by ‘.’), but the ex-
change is blocked in E** (binding signi¢ed by ‘s ’ and ‘D’). d: In
contrast, NAD(H) can freely and rapidly exchange with the solvent
from all states. The model shown here (and that discussed in the
text) is based on the notion that protonation from the p phase fol-
lows NADP binding, and that deprotonation to the n phase pre-
cedes NADPH release [45], but equivalent considerations apply to
an alternative model (in which deprotonation to the n phase follows
NADP binding, and protonation from the p phase precedes
NADPH release). Note that the equilibrium constant for hydride
transfer on the enzyme with physiological nucleotides is approxi-
mately 10 (compare with the value of V1.0 in free solution), and
this biases the reaction in the forward direction at this step [35,77].
Since the binding a⁄nity of dI for NADH is V10-fold greater than
that for NAD [46], the a⁄nity of dIII for NADPH in the E**
state (signi¢ed ‘D’) is 100-fold greater than that for NADP (signi-
¢ed ‘s ’). Isolated complexes of recombinant dI and dIII can only
perform the reactions within the dashed box; in the absence of in-
teractions with dII, inter-conversion between E* and E** is pre-
vented (see text).
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[61] that the amino acid sequence of dI is similar to that of the
soluble enzyme, alanine dehydrogenase, whose crystal struc-
ture was solved to 2.0 Aî resolution in 1998 [62], and on this
basis, a model of the 3-D structure of dI has been proposed
[63] (see Fig. 1). The model structure has two domains. The
NAD(H)-binding domain, dI.2, is linked by two long helices
to domain dI.1, of unknown function. As in alanine dehydro-
genase, the nicotinamide ring of the bound nucleotide is
thought to be located deep within a cleft between domains
I.1 and I.2.
In the dI protein, but not in alanine dehydrogenase, there is
a segment of 20 amino acid residues, which is su⁄ciently
mobile to be observable by NMR spectroscopy [47,63,64].
Upon NAD(H) binding, this ‘mobile loop’ closes down on
the surface of the protein and makes contact with the nucleo-
tide. Mutational analysis [65^68] shows that the loop is im-
portant in catalysis ; it was suggested to have a role in the
relative positioning of the nicotinamide rings of NADH and
NADP prior to hydride transfer.
6. The high-resolution structure of the dIII component of
human transhydrogenase
The crystal structure of recombinant dIII from human-
heart transhydrogenase was recently solved by X-ray di¡rac-
tion at 2.0 Aî resolution [69]. The structure comprises an open,
twisted L sheet of six parallel strands, £anked by helices. As in
the ‘classical’ lactate-dehydrogenase fold, a paradigm for the
structure of many other dinucleotide-binding proteins [70]
(and see review [71]), there are two LKLKL motifs linked by
a crossover helix. NADP is bound to dIII by loops at the C-
terminal edge of the L sheet but its orientation is reversed
relative to nucleotide binding in classical structures. Thus,
the adenosine moiety in dIII is bound predominantly within
the ¢rst LKLKL motif, and the NMN moiety within the sec-
ond. Remarkably, a ¢ngerprint sequence (G-X-G-X-X-A/V) is
found in its ‘usual’ position in the ¢rst LKLKL motif but, in
dIII, the sequence is not associated with pyrophosphate bind-
ing.
As in other dinucleotide-binding sites, the adenine ring is
buried in a hydrophobic crevice (formed predominantly by
amino acid side chains in the C-terminal loops of strands
L1, L5, L6) (see Figs. 3 and 4). The speci¢city of dIII for
NADP(H) relative to NAD(H) is determined by numerous
H-bond and electrostatic interactions between K999, R1000
and S1001 and the 2P-phosphate group of the adenosine ri-
bose. The nicotinamide ring of NADP is bound only by a
single loop at the C-terminus of strand L2. It is positioned at
the end of a ridge, de¢ned mainly by the well-conserved and
hydrophobic helix B, which separates two, relatively £at pro-
tein surfaces. In the complete enzyme, the ridge on dIII is
presumably inserted into the putative cleft on dI (see above,
and Fig. 1) to permit mutual approach of the two nicotin-
amide rings. In the crystal structure of isolated dIII the pro-R
(or A) face of the bound NADP is shielded from the solvent,
but its pro-S (or B) face is largely exposed, notably around the
C4 atom. Thus the pro-S face will be involved in the apposi-
tion with NADH, explaining the 4B stereochemistry of direct
hydride transfer to NADP [27].
The ‘back’ of dIII is covered by weakly conserved amphi-
pathic K helices (0, A and F), which are probably exposed to
the solvent also in the complete enzyme. Taking due account
of the likely position of the dI component, this strongly sug-
gests that the membrane-spanning dII must interact with the
‘front’ of dIII (Fig. 1), where we ¢nd the distinctive structural
feature, helix-D/loop-D. Helix-D projects almost perpendicu-
larly from the L sheet. It emanates from the C-terminus of
strand L4, where the chain turns sharply under the pyrophos-
phate group of the nucleotide. At the C-terminus of helix-D,
the polypeptide makes a series of turns and, as the relatively
extended loop-D, runs back towards the sheet, approximately
antiparallel with helix-D. If the expected arrangement of the
three subunits in the complete enzyme is correct, then helix-D/
loop-D of dIII makes contacts with the loops between the TM
helices of dII. The N-terminus of the recombinant dIII protein
(M837) is close to the C-terminus of the last predicted TM
helix of dII. The ¢rst 21 residues are disordered in the crystal
structure of dIII, and the region is protease-sensitive in the
complete enzyme [19,20], indicating that it might be £exible
linker with the membrane component.
Adjacent to helix-D is loop-E, which arises from the C-
terminus of strand L5, and which arches over the nucleotide
like a lid. At the apex of loop-E is Y1006. This residue, and
Y890, which protrudes from the C-terminus of strand L1,
‘sandwich’ the guanidinium group of R925 (from the loop
which binds the nicotinamide ring, see above). Y890 (actually,
the second residue in the ¢ngerprint sequence), is positioned
by a kink introduced into strand L1 by P888.
There is an extremely interesting set of H-bond interactions
between helix-D, loop-E, including Y1006 and its associated
Y890 and R925, and the ribose and pyrophosphate groups of
the bound NADP, that we believe are involved in energy
transmission in the complete enzyme. Thus, there are exten-
sive H-bond contacts between residues in helix-D (N966,
D967 and T968) and the pyrophosphate, and both ribose
groups, of the nucleotide. Each of the residues in the sandwich
triad, also makes an H-bond with the pyrophosphate (and
R925 also with the NMN ribose). Residues in helix-D (again
including N966 and D967) are in H-bond contact with resi-
dues in loop-E (including G1003, Y1006, A1007 and N1011).
The fact that N966 and D967 have H-bonds with both the
pyrophosphate group and loop-E might be particularly signif-
icant (see below). The carboxylate of D967 and the NMN-
phosphate group are both buried in the protein. Their charges
are partly compensated by H-bond interactions; that between
the carboxylate of D967 and the amide of A1007 is a short-
range interaction (2.62 Aî ).
Determinations of secondary-structure elements by NMR,
¢rstly of R. rubrum dIII [72,73], and later of E. coli dIII
[74,75], have been published. The secondary-structure assign-
ments are generally consistent with the crystal structure of
human dIII (see above) though, in both cases, there are minor
di¡erences. From both sets of NMR data, it was suggested
that dIII adopts the Rossmann fold. However, the ‘global
fold’ model predicted for the E. coli protein [75] has major
di¡erences in the relative disposition of the helices, strands
and loops, and in the identi¢cation of some of the short heli-
ces, with the tertiary structure of human dIII determined by
X-ray crystallography. These di¡erences might simply arise
from the rather limited number of measurements (31 NOEs
between the backbone amide groups of L strands, and 16
NOEs between side-chains). The NMR structure of R. rubrum
dIII (with bound NADP), which is based on s 1800 unam-
biguous NOEs, of which s 100 are between L strands, s 100
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are between strands and helices and s 560 are between pro-
tons more than 6 residues apart, and on angle constraints (M.
Jeeves, K.J. Smith, P.G. Quirk, N.P.J. Cotton and J.B. Jack-
son, manuscript in preparation), is considerably closer to the
crystal structure of human dIII.
7. Conclusions and comments on the mechanism of energy
transduction in transhydrogenase, from observations on the
crystal structure of dIII
7.1. The E**sNADP+ intermediate in catalysis
It was suggested [11,30,35,48] that isolated, recombinant
dIII.NADP in solution (and in its complex with isolated dI
in solution) is locked into a conformation which is similar to
that of dIII in the reaction intermediate, E**sNADP, of
the complete enzyme (Fig. 2). This putative intermediate di-
rectly precedes the hydride transfer step, and, to minimise slip
in the mechanism, exchange of nucleotide between the protein
and the solvent must be prevented in this state (see legend to
Fig. 2). These are, indeed, well-characterised properties of
isolated dIII; the protein can carry out rapid hydride transfer
when in complex with recombinant dI [26,34,35], and it re-
leases bound NADP and NADPH at only extremely low
rates [30,32,33]). Thus, we suggest that the crystal structure
of isolated dIII.NADP is representative of that of dIII in
E**sNADP. In this conformation, the nicotinamide ring,
exposed on the helix-B ‘ridge’, is poised ready to accept a
hydride equivalent (see above). The restricted rate of release
of nucleotide is probably a consequence of the arrangement of
loop-E and the Y890/R925/Y1006 triad, which form a lid, or
cage, over the pyrophosphate and NMN ribose moieties (Figs.
3 and 4).
7.2. Generation of the E**sNADP+ intermediate
In the scheme of Fig. 2, E**sNADP is generated from
E*.NADP by protonation of the enzyme from the p side of
Fig. 3. High-resolution structure of dIII from human transhydrogenase. The program GRASP [78] was used to show the molecular surface of
the protein. Positive and negative Coulombic ¢elds are represented by blue and red, respectively. NADP is shown as a stick model. The inset
gives the view of the protein along the direction of the arrow. Note the ‘lid’ over the bound NADP formed by R925 and Y1006 (see text).
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the membrane. This is the ¢rst power stroke in the reaction,
the second being the conversion of E**DNADPH to
E*.NADPH with proton release to the n side. E* is a state
from which NADP (or NADPH) can exchange rapidly with
the solvent. It is suggested that, in this state, amino acid
residues in the apex of loop-E (e.g. Y1006) are farther away
from helix-D and from Y890/R925 than in the dIII.NADP
crystal form. With the lid in this open conformation, the
pyrophosphate group of the nucleotide is less deeply buried,
and this permits more rapid binding/release of nucleotide. To
prevent redox slip on E*, hydride transfer between nucleotides
on dI and dIII, is blocked (Fig. 2). We propose that, in this
conformation, the nicotinamide rings of NAD(H) and
NADP(H) are farther apart than they are in E**. A possible
site for binding the nicotinamide ring of NADP(H) in the E*
state is an adjacent pocket, which in the crystal structure
(E**, see above) is occupied by glycerol. The necessary move-
ment can be achieved by rotating the NMN-ribose moiety
about the O^P^O bonds of the nicotinamide-pyrophosphate
group (Fig. 4). The swivelling movement would be facilitated
by moving back loop-E ^ as indicated above, loop-E is ex-
pected to be open in the E* state.
It is probably of some signi¢cance that several distinctive
structural features of the dIII protein focus on the pyrophos-
phate group of the bound nucleotide (see above). It is sug-
gested that the seminal ionisation/conformational changes in
dIII, which are primarily responsible for changing NADP(H)
binding during the transition from E* to E** to enable the
hydride transfer step, take place at the N-terminus of helix-D,
in the region of N966 and D967. Both residues are invariant,
and mutation of the residue equivalent to D967 in E. coli
transhydrogenase has pronounced e¡ects on transhydrogena-
tion [58,76]. We suggest this region is the catalytic centre for
energy conversion. Concerted changes in the intricate set of
interactions between N966, D967, residues in loop-E including
Y1006, Y890/R925 and the nucleotide pyrophosphate group,
all of which are in the same locality, could lead to the relative
movements of the NADP and protein which are responsible
for this power stroke of the transhydrogenase reaction, (a) to
bring the C4 atom of the nicotinamide ring, from a distal
position (relative to that of NADH), e.g. in the ‘glycerol pock-
et’, into a proximal position, in the C-terminal loop of strand
L2, and (b) to prevent release of the bound NADP, by clos-
ing the loop-E lid, over the pyrophosphate group, against
loop-D and Y890/R925. These proposed conformational
shifts would not involve signi¢cant changes in the interactions
between the adenine, and the adenosine-ribose groups, and
the protein. The extensive contacts between the 2P-phosphate
of the adenosine ribose and the N-terminal region of loop-E,
as well as determining the nucleotide speci¢city (see above),
will also, therefore, provide a fulcrum for the opening of this
loop.
The important question remains, as to how the energy re-
leased by proton conduction through dII is transmitted to the
catalytic centre. Conceivably, dII and the protruding part of
helix-D in dIII could serve as a conductance pathway to in-
troduce protons into the centre; changes in the protonation
state of, for example, D967 or the nucleotide pyrophosphate
group can be envisaged to result in su⁄ciently large displace-
ments of the nicotinamide ring and loop-E to account for the
events depicted in Fig. 2. The proton e¥ux channel might
involve the pyrophosphate group itself. Alternatively, confor-
mational changes resulting from proton translocation could
be propagated closer to, or below, the membrane surface,
and transmitted to the catalytic centre through helix-D over
a distance of several Aî ngstrom units. In this case the proton
e¥ux channel need not proceed through dIII. There is very
little biochemical evidence to discriminate between these two
possibilities (see [48]).
7.3. Conformational changes accompanying the conversion of
E**.NADP+ to E**.NADPH
The conversion of E**.NADP to E**.NADPH by hydride
transfer from NADH is accompanied by a change in access of
the p and n proton channels of transhydrogenase (Fig. 2).
Di¡erences in the HSQC-NMR spectrum of isolated R. ru-
brum dIII.NADP were observed upon substituting the
bound nucleotide with NADPH [73]. The HSQC experiment
provides information on changes in the magnetic environment
of amide groups in the protein. Mapping the changes on to
the crystal structure of human dIII indicates that reduction of
NADP causes conformational changes, not unexpectedly, in
the backbone amides of residues in the nicotinamide-binding
region, but also throughout helix-D/loop-D and in loop-E
[69]. Evidently information on the redox state of the bound
nucleotide is transmitted into the part of dIII that is thought
to interact with dII (see above). It is tempting, therefore, to
suggest that this information relay is associated with the gat-
ing of the proton channels.
8. Concluding remarks
There are strong indications that proton translocation by
transhydrogenase is associated with changes in the mode of
binding of NADP and NADPH to the dIII component of
the enzyme. Features in the high-resolution crystal structure
of human dIII.NADP provide a basis for understanding the
mechanism of the reaction. (1) The stereochemistry of hydride
transfer, and the speci¢city of NADP(H) over NAD(H), are
clearly explained by structure in and around the nucleotide-
binding pocket. (2) The movement of a ‘lid’ over the pyro-
phosphate group of the nucleotide is responsible for a neces-
sary restriction in the rate of NADP(H) release during catal-
ysis. (3) A cluster of amino acid residues at the N-terminus of
helix-D is centrally involved in coupling the energy available
from vp to changes in NADP(H) binding.
Fig. 4. The NADP-binding site and the ‘glycerol pocket’ of trans-
hydrogenase dIII. The nucleotide in heavy shading indicates its posi-
tion in the crystal structure; that in light shading indicates a possi-
ble position when the protein is in the E* state (see text and Fig.
2). The numbers of some amino acid residues are shown; others
are: H = H920, V = V922, D = D967, I = I981.
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